Apatinib enhances targeted immunotherapy via the IL-6-gp130-PI3K pathway in HER2-positive gastric cancer

Cancer Biology & Medicine · Published 2026-07-20 · DOI 10.20892/j.issn.2095-3941.2025.0687

Free full text

Authors (9)

Ruoxi Tian, Ziyue Sha, Shasha Zhang, Miao Gong, Jianhua Wu, Juntao Lu, Wei Guo, Zhaoxu Zheng, Zhanjun Guo

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Tian, R., Sha, Z., Zhang, S., et al. (2026). Apatinib enhances targeted immunotherapy via the IL-6-gp130-PI3K pathway in HER2-positive gastric cancer. Cancer Biology & Medicine. https://doi.org/10.20892/j.issn.2095-3941.2025.0687

Related articles